Literature DB >> 29307212

Palliative care for Parkinson's disease.

Jeffrey Sheung Ching Ng1.   

Abstract

Parkinson's disease (PD) is a slowly progressive multi-system neurodegenerative disorder, with no available disease-modifying treatment. The disease is associated with motor and non-motor symptoms leading to impaired quality of life, disability and signi cant caregiver distress. Patients with PD bene t from palliative care which provides a holistic approach to meet their multi-faceted needs, including symptom control, communication needs and caregiver support. This article would review on recent articles addressing palliative care for PD.

Entities:  

Keywords:  Parkinson’s disease (PD); motor symptoms; palliative care; prognostication

Mesh:

Year:  2018        PMID: 29307212     DOI: 10.21037/apm.2017.12.02

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  5 in total

1.  Knockdown of SNHG14 Alleviates MPP+-Induced Injury in the Cell Model of Parkinson's Disease by Targeting the miR-214-3p/KLF4 Axis.

Authors:  Shufang Zhou; Dan Zhang; Junnan Guo; Junshi Zhang; Yong Chen
Journal:  Front Neurosci       Date:  2020-09-21       Impact factor: 4.677

2.  The effect and safety of ropinirole in the treatment of Parkinson disease: A systematic review and meta-analysis.

Authors:  Jiali Zhu; Min Chen
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

3.  Evaluation of Patients with Parkinson's Disease in Intensive Care Units: A Cohort Study.

Authors:  Álvaro Réa-Neto; Bruna C Dal Vesco; Rafaella S Bernardelli; Aline M Kametani; Mirella C Oliveira; Hélio A G Teive
Journal:  Parkinsons Dis       Date:  2021-11-05

4.  Tilianin attenuates MPP+-induced oxidative stress and apoptosis of dopaminergic neurons in a cellular model of Parkinson's disease.

Authors:  Jie Li; Sui Xu
Journal:  Exp Ther Med       Date:  2022-02-17       Impact factor: 2.447

Review 5.  Recommendations for Standards of Network Care for Patients with Parkinson's Disease in Germany.

Authors:  Tino Prell; Frank Siebecker; Michael Lorrain; Carsten Eggers; Stefan Lorenzl; Jochen Klucken; Tobias Warnecke; Carsten Buhmann; Lars Tönges; Reinhard Ehret; Ingmar Wellach; Martin Wolz
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.